506260 logo

Anuh Pharma Limited Stock Price

BSE:506260 Community·₹8.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

506260 Share Price Performance

₹82.55
-27.73 (-25.14%)
₹82.55
-27.73 (-25.14%)
Price ₹82.55

506260 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet second-rate dividend payer.

3 Risks
1 Reward

Anuh Pharma Limited Key Details

₹7.3b

Revenue

₹5.7b

Cost of Revenue

₹1.6b

Gross Profit

₹1.2b

Other Expenses

₹387.1m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 14, 2026
3.86
21.45%
5.30%
0%
View Full Analysis

About 506260

Founded
1960
Employees
295
CEO
Ritesh Shah
WebsiteView website
www.anuhpharma.com

Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.

Recent 506260 News & Updates

Recent updates

No updates